Soc. Generale Call 300 SQN 20.09..../ DE000SW7WYQ6 /
28/05/2024 08:12:51 | Var.-0.03 | Denaro14:39:46 | Lettera14:39:46 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.97EUR | -3.00% | 1.01 Quantità in denaro: 4,000 |
1.06 Quantità in lettera: 4,000 |
SWISSQUOTE N | 300.00 CHF | 20/09/2024 | Call |
GlobeNewswire
14:53
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire
14:45
Wearable Devices XR Team's Report: The Mudra’s Neural Technology to Power Future XR Devices
GlobeNewswire
14:45
Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATR...
GlobeNewswire
14:40
AITX’s RAD Announces First Paid Analytic based on Vast Improvements in Its Firearm Detection Speed &...
GlobeNewswire
14:39
Specialized Education Services, Inc. Unveils 2024 Staff and Teacher of the Year Winners
GlobeNewswire
14:31
Mama’s Creations to Host First Quarter and Fiscal Year 2025 Earnings Call on June 11 at 4:30 p.m. Ea...
GlobeNewswire
14:30
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Press...
GlobeNewswire
14:30
Nano Dimension Is Partnering with Esko and Fiery to Provide an End-To-End Industry 4.0 Solution
GlobeNewswire
14:30
SRIVARU (SVMH) Announces the Completion of State-of-the-Art Factory and Fully Automated EV Motorcycl...
GlobeNewswire
14:30
GunBroker Partners with Gearfire Capital to Offer Innovative Financing Solutions for Firearms Retail...
GlobeNewswire
14:30
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Dist...
GlobeNewswire
14:30
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Va...
GlobeNewswire
14:30
Golden Triangle Ventures, Inc. Announces Strategic Agreement with T&K Zarro, LLC to Strengthen Capit...
GlobeNewswire
14:30
Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
GlobeNewswire
14:30
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depre...